538(top 1%)
papers
28.7K(top 1%)
citations
74(top 1%)
h-index
159(top 0.1%)
g-index
573
all documents
29.9K
doc citations
2.9K
citing journals

Top Articles

#TitleJournalYearCitations
1Sildenafil Citrate Therapy for Pulmonary Arterial HypertensionNew England Journal of Medicine20052,237
2Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology20041,542
3Diagnosis and Assessment of Pulmonary Arterial HypertensionJournal of the American College of Cardiology2009984
4Ambrisentan for the Treatment of Pulmonary Arterial HypertensionCirculation2008967
5Tadalafil Therapy for Pulmonary Arterial HypertensionCirculation2009956
6A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)European Heart Journal2014848
7Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trialLancet, The2008844
8Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trialJournal of the American College of Cardiology2002584
9A meta-analysis of randomized controlled trials in pulmonary arterial hypertensionEuropean Heart Journal2008553
10Guideline of transthyretin-related hereditary amyloidosis for cliniciansOrphanet Journal of Rare Diseases2013525
11Complications of Right Heart Catheterization Procedures in Patients With Pulmonary Hypertension in Experienced CentersJournal of the American College of Cardiology2006498
12Updated Evidence-Based Treatment Algorithm in Pulmonary Arterial HypertensionJournal of the American College of Cardiology2009463
13Treatment of Pulmonary Arterial Hypertension With the Selective Endothelin-A Receptor Antagonist SitaxsentanJournal of the American College of Cardiology2006462
14Right heart thrombi in pulmonary embolismJournal of the American College of Cardiology2003445
15The endothelin system in pulmonary arterial hypertensionCardiovascular Research2004412
16Monitored Atrial Fibrillation Duration Predicts Arterial Embolic Events in Patients Suffering From Bradycardia and Atrial Fibrillation Implanted With Antitachycardia PacemakersJournal of the American College of Cardiology2005375
17Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary HypertensionJournal of the American College of Cardiology2009353
18Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)European Heart Journal2014347
19Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic EventsJournal of Cardiovascular Electrophysiology2009341
20Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitroBMC Developmental Biology2007337
21Effects of the oral endothelin-receptorantagonist bosentan on echocardiographicand doppler measures in patients with pulmonary arterial hypertensionJournal of the American College of Cardiology2003334
22BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysisLancet Respiratory Medicine,the2016307
23Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisBMJ: British Medical Journal2008270
24Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General RegistryAmerican Journal of Medicine2015242
25Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial HypertensionChest2011237
26Treprostinil, a Prostacyclin Analogue, in Pulmonary Arterial Hypertension Associated With Connective Tissue DiseaseChest2004232
27Left Superior Vena Cava Persistence in Patients Undergoing Pacemaker or Cardioverter-Defibrillator ImplantationChest2001224
28End Points and Clinical Trial Design in Pulmonary Arterial HypertensionJournal of the American College of Cardiology2009209
29Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertensionJournal of the American College of Cardiology2004206
30Prognosis and treatment of atrial fibrillation patients by European cardiologists: One Year Follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry)European Heart Journal2014204
31Dilated-Hypokinetic Evolution of Hypertrophic CardiomyopathyJournal of the American College of Cardiology2005199
32Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compactionHeart2007198
33Improving Stroke Risk Stratification Using the CHADS 2 and CHA 2 DS 2 -VASc Risk Scores in Patients With Paroxysmal Atrial Fibrillation by Continuous Arrhythmia Burden MonitoringStroke2011176
34Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cellsBasic Research in Cardiology2005174
35Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapyAmerican Heart Journal2006169
36Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial FibrillationEuropace2015164
37Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular DystrophyStroke2003158
38Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analysesEuropean Heart Journal2010157
39Endothelin receptor antagonists in pulmonary arterial hypertensionJournal of the American College of Cardiology2004153
40Management of Pulmonary Arterial Hypertension Associated with Congenital Systemic-to-Pulmonary Shunts and Eisenmenger???s SyndromeDrugs2008153
41Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat HeartsJournal of Biological Chemistry2007152
42Bicuspid Aortic Valve StenosisJACC: Cardiovascular Interventions2016147
43‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot SurveyAmerican Journal of Medicine2014144
44Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonanceHeart2005142
45Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot RegistryEuropace2015128
46Tadalafil for the Treatment of Pulmonary Arterial HypertensionJournal of the American College of Cardiology2012124
47Prostanoids for Pulmonary Arterial HypertensionTreatments in Respiratory Medicine2003123
48Evidence of a Partial Escape of Renin‐Angiotensin‐Aldosterone Blockade in Patients with Acute Myocardial Infarction Treated with Ace InhibitorsJournal of Clinical Pharmacology1993122
49Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General RegistryEuropace2018118
50Determinants of cardiopulmonary functional improvement after transcatheter atrial septal defect closure in asymptomatic adultsJournal of the American College of Cardiology2004115